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IL-6 plays essential roles in immune response, acute phase reaction, and hemato-
poiesis (1, 2) . It is an essential factor forB cell differentiation to antibody-forming
cells (3) . On the other hand, deregulated expression of the IL-6 gene could be in-
volved in polyclonal plasma cell abnormalities and oncogenesis of plasma cell neo-
plasias(4-8) . IL-6, in fact, functions as apotent growth factor formultiple myelomas
(7), as well as plasmacytomas (9, 10) . Furthermore, we recently demonstrated the
generation of a massive plasmacytosis in IL-6 transgenic mice (11) . Therefore, the
abnormal expression of either the IL-6 or the IL-6-R genes could play an essential
role in plasma cell abnormalities .
The association ofchromosomal aberrations with many murine andhuman tumors
suggests thatDNA rearrangements may constitute a general mechanism for tumor
induction (12) . The slowly transforming retroviruses were shown in some cases to
activate transcription of a particular cellular one gene (13) . The intracisternalA par-
ticle (IAP)' gene is a member of endogenous proretroviral-like elements present in
-1,000 copies per haploid genome of Mus musculus (14) . The IAP gene functions
as movable elements in the mouse genome (15) . The possible role of the IAP gene
in oncogenesis was suggested in several studies (16-19) .
In this study, we describe the isolation of two species ofthe cDNAs encoding mu-
rine IL-6-R : one is abnormal and the other authentic, from a plasmacytoma cell
line and normal spleen cells, respectively. In thecDNA encoding the abnormal IL-6-R,
the region corresponding to its intracytoplasmic domain was replaced with a part
of long terminal repeat (LTR) of the IAP gene. This replacement could be respon-
sible for the overexpression of IL-6-R on a plasmacytoma cell line . As an in-
tracytoplasmic portion of theIL-6-R is not required for the signal transduction (20),
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the integration of the IAP gene into the receptor gene may function as a positive
selection element for the development of certain plasmacytomas.
Materials and Methods
CellLine andCell Culture.
￿
An IL-6 dependent-T cell line, KT-3 (21), was used for transfec-
tion experiments. KT-3 cells were maintained in RPMI 1640 medium supplemented with
10% FCS, penicillin (50 U/ml), streptomycin (50 lug/ml), 2 mM glutamine, 50 tiM 2-ME,
and 2 ng/ml of human rIL-6.
cDNA Library and Screening.
￿
cDNA libraries were made utilizing X phage gt10 from
poly(A)' RNA isolated from plasmacytoma cell line, P3U1, and spleen cells of a BALB/c
mouse, as described previously (22). The P3U1 cDNA library was probed with an Fsp I-Ban I
fragment ofthe pBSF2R.236 insert cDNA encoding human IL-6-R (23). Plaques were blotted
on Colony/Plaque Screen membranes (New England Nuclear, Boston, MA) and hybridized
in I% SDS, 1 M NaCl, 0.05 M Tris HCl (pH 7 .5), 5 x Denhardt's solution, and 200 p.g/ml
salmon sperm DNA at 65'C for 16 h and washed in 2 x SSC and 1% SDS at 60'C. To get
X P2 and A 301, the libraries were probed with an Eco RI-Bam HI fragment (probe 1) or
a Fok I-Hind III fragment (probe 2) ofX Pl cDNA, as indicated in Fig. 1 a. The filters were
hybridized as above and washed in 0.1 x SSC and 0.1% SDS at 65°C.
DNASequencing.
￿
The phage insert cDNAs from positive plaques were cloned into pUC18
and sequenced by utilizing Sequenase (United States Biochemical Corp., Cleveland, OH).
Northern Blot Analysis.
￿
Cytoplasmic poly(A)' RNAs (2 Wg/lane of RNA obtained from
a variety of tissues of BALB/c mouse and various plasmacytoma cell lines [kindly provided
by Dr. S. Ohno, Cancer Research Institute, Kanazawa University, Kanazawa, Japan] except
for P3U1; 8 tig/lane RNA from various kinds of cell lines; 1 /cg/lane RNA of P3U1) were
separated on 1% agarose-formaldehyde gels, transferred to GeneScreen Plus membranes (New
England Nuclear), and hybridized with "P-labeled Eco RI-Bam HI fragment of X PI in-
sert cDNA (Fig. 1 a, probe 1) in 50% formamide, 1% SDS, 1 M NaCl, and 10% dextran
sulfate at 42°C for 16 h. Filters were washed in 2 x SSC and SDS at 60°C.
Transfection Experiments andProliferation Assay.
￿
The Eco RI insert cDNA of X PI was sub-
cloned at an Eco RI site of pM5G expression vector, kindly provided by Dr. W. Ostertag
(24). A Kpn I site of X 301 was blunted and replaced with an Eco RI site. The 1,410-bp Eco
RI fragment, which contains authentic IL-6-R cDNA lacking a 3' noncoding region, was
subdoned at an Eco RI site of pM5G. KT-3 cells were transfected with pM5G containing
either X P1 or X 301 insert cDNA by electroporation. Selection of transfectants was started
on day 3 after transfection with 750 pg/ml of the antibiotic G418 (Sigma Chemical Co., St.
Louis, MO).
Stable transfectants (2.5 x 103 cells) were cultured in the presence of various concentra-
tions ofmurine rIL-6, kindly provided by Dr. Y. Akiyama (Ajinomoto Co., Kawasaki,Japan)
or human rIL-6 (25) for 66 h. The cells were pulsed with 0.5 tLCi [3H]TdR during the last
6 h and harvested on glass filter paper by an automatic cell harvester (Labo Mash Science
Co., Tokyo, Japan). The radioactivity was measured with a scintillation counter (Beckman
Instruments, Inc., Fullerton, CA).
Results and Discussion
Murine IL-6-R. cDNA clones were isolated from the cDNA library of P3U1 cells
that were derived from a BALB/c plasmacytoma cell line, MOPC21. Clones that
crosshybridized to the human IL-6-R cDNA, pBSF2R.236 (23), were screened under
a nonstringent condition by in situ procedure. 15 positive plaques were identified
from 7.3 x 105 plaques. One of them, containing the largest insert cDNA, desig-
nated X P1 (Fig. 1 a), was further analyzed. The complete nucleotide sequence of
the cDNA insert of X PI demonstrated that the cDNA consisted of 1,470 by and
contained a large open reading frame that could encode 440 aminoacids (Fig. 1 b).SUGITA ET AL.
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The overall homology with human IL-6-R was 66 and 48% at the DNA and the
protein levels, respectively . The hydrophobic regions corresponding to a signal se-
quence and a transmembrane domain showedmuch higher homology (74and79%
at the protein level, respectively) . The domain of the Ig superfamily found in the
human IL-6-R was also identified in the molecule encoded by the cloned cDNA .
All cysteine residues present in the human IL-6-R were found to be conserved in
this murine molecule, except for Cys211 (human). Furthermore, Trp134 (human) res-
idue and Trp3°s-Ser-X,xxTrp-Ser3°1 (human) sequence were also found at positions
130 and 300-304, respectively . These residues and four Cys residues (at positions
121, 132, 165, and 176 in humanIL-6-R)were found to be conserved amongmurine
erythropoietin R, human IL-2-R (3 chain, murine IL-4-R, and human granulocyte-
macrophageCSFR, and these receptors have been classified as the IL receptor family
(26-30) . Alldata indicated that the XP1 insertcDNA encoded murine IL-6-R . How-
ever, theintracytoplasmic domain ofthemolecule encodedby thecloned cDNA had
no homology with that of the human IL-6-R . It was found that the nucleotide se-
quence ofthecDNA corresponding to the intracytoplasmic domain showed a striking
homology (94%) with that of a part of LTR of the IAP gene (Fig. 1 c) .
Northern blot analysis utilizing the cDNA fragment (Fig . 1 a, probe 1) specific
to the extracytoplasmic domain detected two species ofmRNA (1.8 and 5 .5 kb) in
P3U1 cells (Fig . 2 a) . One majormRNA species had a compatible size (1 .8 kb) with
the cloned XP1 insert cDNA . But the othermRNA species, the expression ofwhich
was much lower than the former one, had a larger size (5.5 kb), compatible with
that ofhuman IL-6-R mRNA . Furthermore, the former mRNA species was shown
to be hybridized with an IAP-LTRspecific cDNA fragment (Fig . 1 a, probe 2), but
the latter mRNA was not (data not shown) . Moreover, only the second species of
themRNA (5.5 kb)was expressed in the spleen, thymus, andliverofBALB/c mouse,
as well as other cell lines, such as theTcell lymphoma cell line, EL-4, and the mac-
rophage cell line, P388D1 (Fig. 2 a) . Thedata indicated thepresence ofIL-6-R mRNA
without the IAP-LTR. To isolate this mRNA clone, cDNA clones were obtained
that were hybridized with probe 1 but not probe 2 . Under these conditions, one
clone (A P2) from the P3U1 cDNA library and 13 clones from the BALB/c spleen
cDNA librarywere obtained . The nucleotide sequences ofAP2 anda representative
clone, A 301 obtained from the BALB/c mouse spleen cDNA library, were deter-
mined . In both cDNAs, the nucleotide sequence, as well as deduced amino acid
sequence corresponding to both an extracellular and atransmembrane region, were
found to be identical with those of theX PI cDNA, although theX P2 insert cDNA
lacked a part of 5' region (Fig . 1 a) . However, the region corresponding to an in-
tracytoplasmic region, as expected, did not contain the IAP-LTR gene and showed
a significant homology with that ofhuman IL-6-R (53% at the protein level) (Fig .
1 b) . Therefore, these cDNA clones were concluded to encode the authentic murine
IL-6-R and the overall homology between murine andhuman IL-6-R was 69 and
54% at DNA and protein levels, respectively .
To examine whether the IL-6-R with its intracytoplasmic portion encoded by a
part of the IAP-LTR gene can transduce the signals, the insert cDNA ofX PI was
subcloned at an Eco RI site ofpM5G expression vector (24) and transfected to an
IL-6-dependent humanT cell line, KT -3 (21) . Human IL-6 induced cell growth of
KT-3 cells, but murine IL-6 did not. However, KT -3 cells transfected with either2004 MURINE INTERLEUKIN 6 RECEPTOR mRNA IN A PLASMACYTOMA
FIGURE 1 .
￿
(a) Restriction en-
donuclease cleavage maps ofthe
cDNAs encoding abnormal and
authentic murine IL-6-R . The
open reading frames correspond-
ingto the IL-6-R are also shown
by solid boxes : SS, signal se-
quence; EC, extracellular do-
main;TM,transmembrane do-
main ; C, intracytoplasmic
domain . Abbreviations for re-
strictionenzymes are as follows :
B, Bam HI ; E, Eco RI ; F, Fok
I; H, Hind III ; K, Kpn 1 ; P, Pst
I; S,Sma I .The EcoRI site was
newly introduced to the cDNA
fragments to makecDNA librar-
ies. (b) Comparison of the de-
ducedamino acid sequences of
the cloned murine IL-6-R
cDNAs with human IL-6-R
amino acid sequence. Deduced
amino acid sequences ofthe in-
sertcDNA ofAP1 (:) andX 301
(in) are aligned with that of hu-
man IL-6-R cDNA,pBSF2R236
(23) (ie). The deduced amino
acid sequence between positions
of 1and357 ofthe insertcDNA
of X 301 was identical with
that ofthe insert cDNA ofXPI
(data notshown) . Gaps are in-
troduced for optimal sequence
alignment. The signal sequence,
the domain similar tothe Ig su-
perfamily, and a transmem-
brane domain are underlined .
Identical amino acids are indi-
cated by asterisks . Conserved
cysteine residues are boxed .
Some of abnormal orauthentic
murine IL-6-R cDNA clones
were found to be defective in
three base pairs, resulting in the
lack ofAla 4 (data not shown).
(c) Comparison ofthe nucleotide
sequences ofthe 3' region ofthe
insert cDNA of X PI (top lines)
and that of the IAP-LTR se-
(continued)
the X P1 or X 301 cDNA responded to murine IL-6 to proliferate (Fig . 3) . The data
indicated that the IL-6-R, in which an intracytoplasmic domain was replaced with
the molecule encoded by a part of the IAP-LTR gene, could function and transduce
the signals . This wasin complete agreementwith ourprevious observation withhuman
IL-6-R that an intracytoplasmic domain was not required for the signal transduc-
tion (20) .C
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3113 TCCCCGTGACGTCAACTCGGCCGATGGGCTGCAGCCAATCAAGGAGTGATACGTCCGAGG
CAT box
1338 CGAAGGATAATTCTCCTTAATAGGGACGGGG-TTTCGTTTTCTCTCTCTCTTGCTTC --T
3173 CGAAGGLUGAATGCTCCTTAAGAGGGACGGGGTTTTCGTTTTCTCTCTCTCTTGCTTCTTG
TATA box
￿
U34--L--->R
1455 AGCTTTGCCGCAGAAG
rffrlfr+"trfr
3293 AGCTTTGCCGCAG
REJ
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1395 CTCTCTTGCTTCTTGCTCTCTTGCTTCCTGCACCCTGGCTCCTGAAGATGTAAGAAATAA
3233 CTCTCTTGCTTCTTGCTCTCTTGCTTCCTGCACCCTGGCTCCTGAAGATGTAAGAAATAA
poly A
signal
FIGURE 2 .
￿
Expression of IL-6-RmRNA in a variety of cellsand cell lines (a)andplasmacyto-
mas (b) . Cytoplasmic poly(A)' RNAs (2 jig/lane ofRNAobtained from the spleen, thymus, liver,
kidney, and brain of BALB/c mouse and various plasmacytoma cell lines, except for P3U1 ; 8
pg/lane of RNA from various kinds of cell lines; 1 Pg/laneRNA of P3U1) were separated on
1% agarose-formaldehyde gels, transferred to nylon filters, andhybridized with 32p-labeled Eco
RI-Bam HI fragment ofX PI insert cDNA . P3U1, plasmacytoma cell line ; EL-4, T cell lym-
phoma cell line; P388D1, macrophage-like cell line; WEHI-3B, myelomonocytic leukemia cell
line, 70Z/3, pre-B cell line ; M12,Blymphoma cell line ; ABPC17, ABPC47, ÀBPC52, TEPC1033
and MOPC104E, plasmacytoma cell lines .
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quence of the cDNA encoding
IgE binding factor (bottomlin-.
Glucocorticoid responsive ele-
ment (GRE), enhancersequence,
CATbox, TATA box, and poly
A addition signal are under-
lined .Thewhole nucleotide se-
quences ofthecDNA encoding
murine IL-6-R (X P1 andX301
cDNA)have been submitted to
theEMBL/GenBank Data Li-
braries under the accession
numbersX51976 and X51975,
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IAPhas been demonstrated to act as an insertional element that upregulates (17,
19)or downregulates (31, 32)the relevant gene expression. IAP-LTRconsistsofthree
regions, U3, R, and U5, and is classified into two groups on the basis of the size
ofthe R region (33). IAP-LTR foundin the IL-6-R geneshowed a striking homology
with that found inmurine IgEbinding factor (34) and contained U3 and R regions
in which the enhancer sequence was included (Fig. 1 c). The study ofthe organiza-
tion of the human IL-6-R gene showed that a transmembrane domain and an in-
tracytoplasmic domain ofhuman IL-6-R were encoded by different exons (unpub-
lished data). Therefore, the overexpression ofthe IL-6-R mRNAwith the IAP-LTR
sequence in P3Ul cells could be due to the enhancer activity ofthe IAP-LTR gene
that was supposed to be inserted between the exons encoding a transmembrane and
an intracytoplasmic domain ofthe murine IL-6-R gene. Stabilization ofmRNAmay
be another possible mechanism for the enhanced expression ofthe rearranged IL-
6-R gene with IAP-LTR.
The IAP gene is expressed in early mouse embryos and many murine plasmacy-
tomas (35, 36). The possible role ofthe IAP gene in oncogenesis was suggested in
several studies: the insertion of the IAP gene in the c-mos or the IL-3 gene in plas-
macytoma and a myeloid leukemic cell line resulted in the activation of the c-mos
or the IL-3 gene, respectively (16-19). Overexpression ofIL-6-R maymake cells more
sensitive to IL-6 (20). Since IL-6 is a potent growth factor for plasmacytomas and
deregulated expression ofthe IL-6 gene has been suggested to be involved in the
oncogenesis ofplasma cell neoplasias (8), the deregulated expression ofthe IL-6-R
gene could contribute to accelerate the IL-6-induced promotion ofthe malignant
transformation of plasma cells. A unique feature of an IL-6-R system consisting
oftwomolecules, aligand bindingchain and a signal transducer, allowedthe IL-6-R
containing themoleculeencoded byapart oftheIAP-LTR geneinsteadofthe normal
intracytoplasmic domain to function for the transduction of the growth signals in
plasmacytomas. Although, the insertion ofthe IAP-LTR gene was not commonly
observed in various plasmacytomas (Fig. 2 b), this rearrangement may provide a
positive pressure for the selection in the development of certain plasmacytomas.
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FIGURE 3.
￿
Murine IL-6-R containing amolecule en-
coded by the IAP-LTR gene can transduce the signal.
(O)KT-3 cells expressing murine IL-6-R containing the
molecule encodedby the IAP-LTR gene instead ofnor-
mal intracytoplasmic domain. (") KT-3 cellsexpress-
ingauthenticmurine IL-6-R. (0) Normal KT-3 cells.
Results areshownas mean t ofquadruplicate cultures.SUGITA ET AL .
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Summary
Two species ofthecDNAs encoding murine IL-6-R (one is abnormal and the other
authentic) have been cloned from a plasmacytoma cell line, P3Ul, and BALB/c mouse
spleen cDNA libraries . In the cDNA encoding theabnormal IL-6-R, the region cor-
responding to an intracytoplasmic domain was replaced with a part ofthe long ter-
minal repeat ofthe intracisternalA particle gene (IAP-LTR) . The authenticIL-6-R
consists of 460 amino acids with the domain of the Ig superfamily . The overall ho-
mology between murine and human IL-6-R was 69 and 54% atDNA and protein
levels, respectively. The extracellular domain after the Ig-likedomain ofmurine IL-6-R
was found to have anhomology with those ofmurine erythropoietin R, human IL-
2-R 0 chain, murine IL-4-R, and human granulocyte-macrophage CSF-R, as in
the case ofhuman IL-6-R, and these receptors have been classified as members of
the IL receptor family.
In P3U1 cells, the expression ofthemRNA encoding abnormal IL-6-R was much
higher than that ofthemRNA encoding authentic IL-6-R . An IL-6-dependent human
T cell line, KT3, which did not respond to murine IL-6, acquired the responsive-
ness to murine IL-6 when transfected with the cDNA encoding abnormal IL-6-R,
indicating that abnormal IL-6-R lacking a normal cytoplasmic domain can func-
tion. Since IL-6 functions as a potent growth factor formurine plasmacytomas, over-
expression ofabnormal IL-6-R may function as a positive selection element for the
development of certain plasmacytomas .
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